Biomarkers Require Refining in Lung Cancer Paradigm - OncLive

Biomarkers Require Refining in Lung Cancer Paradigm  OncLive

Hossein Borghaei, DO, discusses pivotal and ongoing trials driven by biomarkers in lung cancer.



Comments

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Stage 4 Lung Cancer Life Expectancy

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...